Location History:
- Goa, IN (2018)
- Sattari, IN (2019)
Company Filing History:
Years Active: 2018-2019
Title: Dnyaneshwar V Gawas: Innovator in Pharmaceutical Processes
Introduction
Dnyaneshwar V Gawas is a notable inventor based in Sattari, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important compounds. With a total of two patents to his name, Gawas has demonstrated his expertise and innovation in this specialized area.
Latest Patents
Gawas's latest patents include a process for the preparation of Ranolazine, which encompasses the creation of its acid addition salts. This invention is crucial for the pharmaceutical industry as Ranolazine is used in the treatment of chronic angina. Additionally, he has developed a process for preparing the potassium salt of Azilsartan Medoxomil. This invention not only relates to the preparation of Azilsartan Medoxomil Potassium but also introduces a novel highly crystalline polymorph of the compound, which is essential for enhancing the stability and efficacy of the medication.
Career Highlights
Dnyaneshwar V Gawas is currently associated with Unichem Laboratories Limited, a prominent player in the pharmaceutical sector. His work at Unichem Laboratories has allowed him to focus on innovative processes that contribute to the development of effective pharmaceutical products. His dedication to research and development has positioned him as a valuable asset in the industry.
Collaborations
Gawas has collaborated with notable colleagues such as Dhananjay Govind Sathe and Sanjay Bhaskar Chowkekar. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical processes.
Conclusion
Dnyaneshwar V Gawas is a distinguished inventor whose work in pharmaceutical processes has made a significant impact. His patents reflect his commitment to innovation and excellence in the field. Through his contributions, he continues to advance the pharmaceutical industry and improve patient outcomes.